| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.920 | 22.385 | 30.849 | 37.596 | 22.502 | 27.946 | 24.763 | 25.329 | 27.887 | 28.781 |
| Total Income - EUR | 18.921 | 22.385 | 30.850 | 37.598 | 23.482 | 27.946 | 24.763 | 25.329 | 27.898 | 28.822 |
| Total Expenses - EUR | 17.889 | 23.594 | 30.343 | 36.361 | 23.155 | 23.377 | 20.250 | 18.669 | 24.023 | 28.466 |
| Gross Profit/Loss - EUR | 1.032 | -1.209 | 506 | 1.238 | 327 | 4.569 | 4.513 | 6.660 | 3.875 | 356 |
| Net Profit/Loss - EUR | 464 | -1.536 | 194 | 861 | 91 | 4.397 | 4.265 | 6.420 | 3.638 | 111 |
| Employees | 2 | 2 | 4 | 3 | 2 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Axa Valirox Mar Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.707 | 8.457 | 9.748 | 8.167 | 7.585 | 6.104 | 4.453 | 2.709 | 3.270 | 6.332 |
| Current Assets | 7.226 | 6.291 | 10.129 | 9.585 | 4.470 | 6.384 | 10.558 | 12.768 | 12.054 | 8.638 |
| Inventories | 236 | 309 | 3.777 | 836 | 0 | 145 | 0 | 331 | 0 | 81 |
| Receivables | 2.276 | 2.363 | 4.448 | 3.177 | 2.325 | 2.868 | 2.338 | 4.218 | 6.399 | 4.387 |
| Cash | 4.715 | 3.619 | 1.903 | 5.573 | 2.144 | 3.371 | 8.220 | 8.219 | 5.655 | 4.171 |
| Shareholders Funds | 4.421 | 2.840 | 2.986 | 3.792 | 3.810 | 8.134 | 12.219 | 12.486 | 12.153 | 12.196 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.512 | 11.909 | 16.891 | 13.961 | 8.245 | 4.354 | 2.792 | 2.990 | 3.170 | 2.774 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Axa Valirox Mar Srl